Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
Active, not recruiting · NCT06332131 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast cancer, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, cardiovascular disorder, heart disorder, injury, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, radiation injury, respiratory system disorder, respiratory tract neoplasm, skin disorder | Active, not recruiting | Not stated | 2026-10-05 | NCT06332131 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Abramson Cancer Center at Penn Medicine | 137 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Abramson Cancer Center at University of Pennsylvania | Philadelphia | United States | 11 |